Unlike most of the existing metabolomics literature, where the role of IR in modulating obesity-related metabolic disturbances has usually been explored by looking for associations with surrogate markers (e.g., HOMA-IR), we have demonstrated that the shape of OGTT-induced insulin curves is a reliable measure to stratify subjects according to disease severity (i.e., early vs. late responders). The gene discussed is INS; the disease is obesity disorder.